{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:52:53Z","timestamp":1776185573842,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,14]],"date-time":"2027-04-14T00:00:00Z","timestamp":1807660800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","award":["X01HD100702"],"award-info":[{"award-number":["X01HD100702"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["X01HD100702"],"award-info":[{"award-number":["X01HD100702"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["U54HL165442"],"award-info":[{"award-number":["U54HL165442"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["F30-CA-268782"],"award-info":[{"award-number":["F30-CA-268782"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U2C CA233285"],"award-info":[{"award-number":["U2C CA233285"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope on Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trecan.2025.12.001","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:31:57Z","timestamp":1766406717000},"page":"348-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSPC-like blasts in acute lymphoblastic leukemia: biology and therapeutic opportunities"],"prefix":"10.1016","volume":"12","author":[{"given":"Jason","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan H.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shovik","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-5567","authenticated-orcid":false,"given":"Kai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","article-title":"Genetics and prognosis of ALL in children vs adults","volume":"2018","author":"Roberts","year":"2018","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.trecan.2025.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","article-title":"Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia","volume":"37","author":"Granja","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0020","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.2019004547","article-title":"Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL","volume":"137","author":"Anand","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0025","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.2021013442","article-title":"Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia","volume":"139","author":"Chen","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41591-022-01720-7","article-title":"Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia","volume":"28","author":"Khabirova","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0040","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1038\/s41467-024-52317-2","article-title":"Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia","volume":"15","author":"Peretz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.2024027270","article-title":"Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome","volume":"145","author":"Chen","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood.2024026482","article-title":"Targeting senescent stemlike subpopulations in Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"145","author":"Ding","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s43018-025-00987-2","article-title":"Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features","volume":"6","author":"Iacobucci","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI109193","article-title":"Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells","volume":"62","author":"Fialkow","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.12.001_bb0065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1126\/science.1073823","article-title":"A stem cell molecular signature","volume":"298","author":"Ivanova","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.12.001_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.12.001_bb0085","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/bloodadvances.2021005741","article-title":"A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia","volume":"6","author":"Ng","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2025.12.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000349","article-title":"Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells","volume":"2","author":"Saito","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nm1253","article-title":"Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia","volume":"11","author":"Castor","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120787119","article-title":"Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases","volume":"119","author":"Dai","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.2023022919","article-title":"Genetic subtypes of B-cell acute lymphoblastic leukemia in adults","volume":"145","author":"Passet","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","article-title":"Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia","volume":"30","author":"Ebinger","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood.V95.3.1007.003k35_1007_1013","article-title":"A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia","volume":"95","author":"Cobaleda","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.V100.2.640","article-title":"Immature CD34+CD19- progenitor\/stem cells in TEL\/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal","volume":"100","author":"Hotfilder","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0125","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood.V97.12.3925","article-title":"Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia","volume":"97","author":"George","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/leu.2014.322","article-title":"Clonal origins of ETV6-RUNX1(+) acute lymphoblastic leukemia: studies in monozygotic twins","volume":"29","author":"Alpar","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2025.12.001_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-981-10-3233-2_14","article-title":"ETV6-RUNX1 (+) acute lymphoblastic leukaemia in identical twins","volume":"962","author":"Ford","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0140","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2009-10-251413","article-title":"Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia","volume":"115","author":"Bateman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/gcc.20671","article-title":"High hyperdiploid childhood acute lymphoblastic leukemia","volume":"48","author":"Paulsson","year":"2009","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/sj.leu.2400754","article-title":"Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia","volume":"11","author":"Quijano","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2025.12.001_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccr.2008.05.015","article-title":"In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties","volume":"14","author":"le Viseur","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.12.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70085","article-title":"Single-cell DNA and surface protein characterization of high hyperdiploid acute lymphoblastic leukemia at diagnosis and during treatment","volume":"9","author":"Aertgeerts","year":"2025","journal-title":"Hemasphere"},{"key":"10.1016\/j.trecan.2025.12.001_bb0165","first-page":"293","article-title":"Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineage directed therapies","volume":"109","author":"Bataller","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.trecan.2025.12.001_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.trecan.2025.12.001_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.12.001_bb0180","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"Gutierrez","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0185","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/pbc.24021","article-title":"Absence of biallelic TCRgamma deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia","volume":"58","author":"Yang","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2232","article-title":"Launching the T-cell-lineage developmental programme","volume":"8","author":"Rothenberg","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ni878","article-title":"Thymopoiesis independent of common lymphoid progenitors","volume":"4","author":"Allman","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0205","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.immuni.2020.03.019","article-title":"Integrated scRNA-Seq identifies human postnatal thymus seeding progenitors and regulatory dynamics of differentiating immature thymocytes","volume":"52","author":"Lavaert","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.12.001_bb0210","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1200\/JCO.22.02734","article-title":"The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia","volume":"41","author":"O'Connor","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae011","article-title":"Decoding the genetic symphony: profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights","volume":"3","author":"Verma","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.trecan.2025.12.001_bb0220","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"Polonen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.12.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231349","article-title":"Native stem cell transcriptional circuits define cardinal features of high-risk leukemia","volume":"222","author":"Wang","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr2012","article-title":"An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup","volume":"17","author":"Gower","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0235","first-page":"9397","article-title":"A non-canonical lymphoblast in refractory childhood T-cell acute lymphoblastic leukemia","volume":"16","author":"Lim","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0240","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0245","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.leu.2404128","article-title":"Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system","volume":"20","author":"Owaidah","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2025.12.001_bb0250","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1182\/blood-2008-10-187351","article-title":"Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital","volume":"113","author":"Rubnitz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.12.001_bb0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2020006996","article-title":"Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia","volume":"137","author":"Alberti-Servera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0265","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1073\/pnas.1420822111","article-title":"Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics","volume":"111","author":"Gawad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.12.001_bb0270","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.12.001_bb0275","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/bloodadvances.2019001008","article-title":"The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2025.12.001_bb0280","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","article-title":"Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001","volume":"6","author":"Tran","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2025.12.001_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jmoldx.2023.09.013","article-title":"Transcriptome sequencing allows comprehensive genomic characterization of pediatric B-Acute lymphoblastic leukemia in an academic clinical laboratory","volume":"26","author":"Hu","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.trecan.2025.12.001_bb0290","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12885-021-08635-5","article-title":"Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia","volume":"21","author":"Walter","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0295","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0300","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1158\/1078-0432.CCR-21-0553","article-title":"Network analysis reveals synergistic genetic dependencies for rational combination therapy in Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"27","author":"Ding","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.12.001_bb0305","doi-asserted-by":"crossref","first-page":"902","DOI":"10.20517\/cdr.2022.78","article-title":"Tyrosine kinases in KMT2A\/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance","volume":"5","author":"Uckun","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.trecan.2025.12.001_bb0310","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.3390\/ijms25136844","article-title":"The role of the JAK-STAT pathway in childhood B-cell acute lymphoblastic leukemia","volume":"25","author":"Zietara","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.12.001_bb0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.12.001_bb0320","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0325","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2025.12.001_bb0330","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.12.001_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/nyas.12362","article-title":"The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment","volume":"1310","author":"Greim","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.trecan.2025.12.001_bb0340","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.hemonc.2019.10.002","article-title":"Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: a case report and review of literature","volume":"14","author":"Farhadfar","year":"2021","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"10.1016\/j.trecan.2025.12.001_bb0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s44228-022-00019-1","article-title":"Azacitidine in combination with venetoclax maintenance post-allogeneic hematopoietic stem cell transplantation in T cell acute lymphoblastic leukemia","volume":"5","author":"Hassan","year":"2023","journal-title":"Clin. Hematol. Int."},{"key":"10.1016\/j.trecan.2025.12.001_bb0350","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1080\/10428194.2021.1957876","article-title":"Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series","volume":"62","author":"Wan","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trecan.2025.12.001_bb0355","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2023-179733","article-title":"Venetoclax combined with azacitidine was effective and safe for relapsed\/refractory T-cell acute lymphoblastic leukemia\/ lymphoblastic lymphoma: preliminary results of a Phase 2, multicenter trial","volume":"142","author":"Cao","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.12.001_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217541","article-title":"The development and potent antitumor efficacy of CD44\/CD133 dual-targeting IL7Ralpha-armored CAR-T cells against glioblastoma","volume":"614","author":"Zhai","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2025.12.001_bb0365","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1158\/0008-5472.CAN-23-0510","article-title":"Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma","volume":"83","author":"Bei","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.12.001_bb0370","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0375","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","article-title":"Natalizumab induction and maintenance therapy for Crohn's disease","volume":"353","author":"Sandborn","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0380","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0385","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0390","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.12.001_bb0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","article-title":"Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101)","volume":"43","author":"Issa","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.12.001_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104783","article-title":"Menin inhibitors in KMT2A-rearranged and NPM1-mutated acute leukemia: A scoping review of safety and efficacy","volume":"213","author":"Dali","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325003085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325003085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:52:56Z","timestamp":1776181976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325003085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2405803325003085"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.12.001","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSPC-like blasts in acute lymphoblastic leukemia: biology and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}